Healthtech Startups

Nymbl provides cloud-based software for orthotic and prosthetic (O&P), custom rehabilitation technology (CRT), and durable medical equipment (DME) practices to manage operations, billing, and patient care. The platform helps healthcare providers streamline administrative tasks, improve billing efficiency, and grow their operations.

3 investors

Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function. It targets both TEER-suitable patients and those with limited existing treatment options in the cardiology/medical device field.

3 investors

NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.

3 investors

OCON Medical develops intrauterine devices for gynecological conditions, including non-hormonal contraception and treatments for abnormal uterine bleeding. The company's products serve women seeking alternatives to hormonal methods and surgical interventions.

3 investors

Odne develops OdneClean, an endodontic irrigation protocol and technology for root canal treatment in dentistry. The company serves dental professionals and endodontists seeking improved cleaning and disinfection of root canal systems.

3 investors

OhMD provides a voice AI system for medical practices that automatically answers routine patient phone calls—such as scheduling, appointment reminders, prescription refills, and general questions—and resolves them by voice or text. It is designed to reduce front desk call volume, lower no-show rates, and ease staff workload for healthcare providers.

3 investors

Oisín Biotechnologies develops non-viral genetic therapies built on its Fusogenix Proteo-Lipid Vehicle (PLV) delivery platform, which delivers DNA and RNA payloads to tissues throughout the body and allows repeat dosing. Its pipeline targets the biology of aging, with programs in targeted fat removal, muscle building, and longevity biology across aesthetic and longevity medicine.

3 investors

Olli Health develops clinical AI technology for home health agencies. The platform serves home health providers to improve clinical outcomes and operational efficiency.

3 investors

Omnicell develops medication management and automation solutions for healthcare facilities, enabling autonomous pharmacy operations across various care settings.

3 investors

Omnidoc provides a medical collaboration platform for healthcare professionals and organizations, offering telexpertise (remote specialist advice), e-RCP (multidisciplinary team meetings), and assisted teleconsultation. It serves public hospitals, ESPIC, CPTS, clinics, and group practices in France, centralizing and securing medical advice exchanges while integrating with existing healthcare tools.

3 investors

ONASPORT is a wearable device that monitors athletic performance through non-invasive analysis of sweat-based biomarkers including lactate, sodium, dehydration, and electrolyte loss. The system connects via Bluetooth to a cloud-based app for iOS and Android, enabling athletes to track training data and manage team performance.

3 investors

Onco provides cancer patients in India with access to expert oncologists, quality treatment centers, discounted cancer medicines, diagnostic tests, and support throughout their treatment journey. The platform connects patients with specialists, offers curated treatment packages, and provides survivor mentorship and remote answers to cancer-related queries.

3 investors

Oncoinvent is a biotechnology company focused on drug development and commercialization in the pharmaceutical sector. The company is led by executives with extensive experience in biotech management, clinical programs, and global pharmaceutical commercialization.

3 investors

3 investors

Oncorena is a Swedish pharmaceutical company developing a breakthrough treatment for metastatic renal cancer based on the drug candidate ONC175 (orellanine). The company targets an orphan drug indication with clinical development underway.

3 investors

OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.

3 investors

One Small Step is a digital platform offering on-demand, certified peer support for people in mental health and addiction recovery, focused on real-time emotional care, crisis prevention, and post-discharge windows when traditional care is unavailable. It targets individuals in recovery as well as healthcare providers and payers seeking a scalable layer in the mental health safety net.

3 investors

Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health. The company operates globally and aims to make remote health monitoring accessible and user-friendly.

3 investors

OneVillage is a personalized health platform that offers employers and their employees customized coaching, benefits management, and health programs. The platform connects individuals with personalized guidance and resources to improve well-being.

3 investors

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.

3 investors

Onsite Dental delivers dental care services in customized practice locations within workplaces, college campuses, and residential buildings. The company operates traditional fixed sites, mobile practices, and pop-up clinics, focusing on accessibility and patient comfort.

3 investors

OODA Health builds patient billing and claims-payment technology that coordinates payers, providers, and patients to handle healthcare payments at the point of care. The company works with U.S. health plans and provider systems and has entered an agreement to be acquired by Cedar.

3 investors

Opalite builds language interpretation technology for healthcare, enabling real-time communication between physicians and patients across language barriers. The platform serves clinicians and care teams to improve patient safety and diagnostic accuracy.

3 investors

Open Bionics develops 3D-printed bionic hands called the Hero Arm, designed to be affordable, functional, and aesthetically appealing alternatives to traditional prostheses. The company serves individuals with upper limb differences and limb loss, operating in the medical devices and assistive technology space.

3 investors